Response to comment on: Gleicher N et al., 2016. Reprod biol endocrinol Sep 5;14(1):54

Reproductive Biology and Endocrinology

Commentary

Jeffrey Braverman¹  Andrea Vidali²  Cynthia Hudson³  Qi Wang³  Yang-Guan Wu³  Lin Zhang³  David H. Barad⁴  Norbert Gleicher⁵  Vitaly A. Kushnir⁶ 

[1] Braverman IVF and Reproductive Immunology, New York, NY, USA;Fertility Specialist in New York, New York, NY, USA;The Center for Reproduction, 21 E 69th St, 10021, New York, NY, USA;The Center for Reproduction, 21 E 69th St, 10021, New York, NY, USA;The Foundation for Reproductive Medicine, New York, USA;The Center for Reproduction, 21 E 69th St, 10021, New York, NY, USA;The Foundation for Reproductive Medicine, New York, USA;The Brivanlou Laboratory for Stem Cell Biology and Molecular Embryology, Rockefeller University, New York, NY, USA;Medical University of Vienna, Vienna, Austria;The Center for Reproduction, 21 E 69th St, 10021, New York, NY, USA;Wake Forest University, Winston Salem, NC, USA;

关键词: Preimplantation genetic screening (PGS);    In vitro fertilization (IVF);    Embryos;    Embryo mosaicism;    Trophectoderm biopsy;    Blastocyst;   

DOI  :  10.1186/s12958-017-0241-x

 received in 2017-03-17, accepted in 2017-03-17,  发布年份 2017

来源: Springer

【 授权许可】

CC BY   
© The Author(s). 2017